RepliCel Life Sciences EV/Sales
Cos'è EV/Sales di RepliCel Life Sciences?
EV/Sales di RepliCel Life Sciences, Inc. è 10.39
Qual è la definizione di EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales di aziende nel Health Care settore su TSXV rispetto a RepliCel Life Sciences
Cosa fa RepliCel Life Sciences?
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
Aziende con ev/sales simili a RepliCel Life Sciences
- Custom Truck One Source Inc ha EV/Sales di 10.38
- Trez Capital Senior Mortgage Investment ha EV/Sales di 10.38
- Imobiliaria Construtora Grao Para, S.A ha EV/Sales di 10.38
- Kansas City Southern ha EV/Sales di 10.38
- C3.ai Inc ha EV/Sales di 10.38
- Procore Technologies ha EV/Sales di 10.38
- RepliCel Life Sciences ha EV/Sales di 10.39
- TC Pipelines, LP ha EV/Sales di 10.42
- NAPCO Security Technologies Inc ha EV/Sales di 10.42
- Bone Therapeutics SA ha EV/Sales di 10.43
- Winfair Investment ha EV/Sales di 10.44
- Mainstreet Equity ha EV/Sales di 10.44
- Hindustan Foods ha EV/Sales di 10.46